the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Trump threatens 25% tariffs on South Korean autos and goods

US President Donald Trump says he will raise tariffs on South Korean cars, lumber and pharmaceuticals from 15% to 25%, citing a trade deal dispute.

WASHINGTON: US President Donald Trump has announced plans to increase tariffs on a range of South Korean goods.

In a post on Truth Social, Trump said he would raise tariffs on South Korean autos, lumber, pharmaceuticals and other items from 15% to 25%.

“South Korea’s Legislature is not living up to its Deal with the United States,” Trump wrote.

He stated the increase was “because the Korean Legislature hasn’t enacted our Historic Trade Agreement, which is their prerogative.”

This move reverses a key part of a trade and security deal finalised in October 2024.

That agreement, struck after Trump met South Korean President Lee Jae Myung, included South Korean investment promises and US tariff cuts.

It specifically reduced US tariffs on South Korean cars from 25% to 15%.

The auto industry constitutes 27% of South Korea’s exports to the United States.

Reverting to 25% tariffs could disadvantage South Korean exports compared to rivals like Japan and the EU.

Those economies have deals securing a 15% US tariff rate.

The Trump administration has not yet issued formal notices to enact the tariff change.

This threat follows recent warnings to other US trading partners.

Trump recently warned Canada he would impose a 100% tariff if it concludes a trade deal with China.

He also previously threatened tariffs on European nations over a potential Greenland purchase before backing down.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings